Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multinational, Multicenter, Non Interventional Study, in Patients With Rheumatoid Arthritis (RA) Treated With Tocilizumab.

NCT01952509 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT01952509
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01952509 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multinational, Multicenter, Non Interventional Study, in Patients With Rheumatoid Arthritis (RA) Treated With Tocilizumab.
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Completed
Start date
October 31, 2013
Completion date
September 30, 2016
Enrollment
169 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis